Hattori, A., Nishikawa, K., Ito, K., Tachikawa, N., Fujibe, K., Tanaka, S., . . . Hataji, O. (2022). Pseudoprogression of lung large cell neuroendocrine carcinoma resembling pancreatic cancer during durvalumab therapy. Clinical Journal of Gastroenterology, 15(3), 668-672. https://doi.org/10.1007/s12328-021-01588-z
Chicago-referens (17:e uppl.)Hattori, Aiji, Kenichiro Nishikawa, Kentaro Ito, Namie Tachikawa, Kodai Fujibe, Syota Tanaka, Michiaki Oiwa, och Osamu Hataji. "Pseudoprogression of Lung Large Cell Neuroendocrine Carcinoma Resembling Pancreatic Cancer During Durvalumab Therapy." Clinical Journal of Gastroenterology 15, no. 3 (2022): 668-672. https://doi.org/10.1007/s12328-021-01588-z.
MLA-referens (9:e uppl.)Hattori, Aiji, et al. "Pseudoprogression of Lung Large Cell Neuroendocrine Carcinoma Resembling Pancreatic Cancer During Durvalumab Therapy." Clinical Journal of Gastroenterology, vol. 15, no. 3, 2022, pp. 668-672, https://doi.org/10.1007/s12328-021-01588-z.
